PL3565823T3 - Peptydy S-arestyn oraz ich zastosowanie terapeutyczne - Google Patents
Peptydy S-arestyn oraz ich zastosowanie terapeutyczneInfo
- Publication number
- PL3565823T3 PL3565823T3 PL18703620.7T PL18703620T PL3565823T3 PL 3565823 T3 PL3565823 T3 PL 3565823T3 PL 18703620 T PL18703620 T PL 18703620T PL 3565823 T3 PL3565823 T3 PL 3565823T3
- Authority
- PL
- Poland
- Prior art keywords
- arrestin
- peptides
- therapeutic uses
- therapeutic
- arrestin peptides
- Prior art date
Links
- 102100022135 S-arrestin Human genes 0.000 title 1
- 101710117586 S-arrestin Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Ophthalmology & Optometry (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201700104 | 2017-01-04 | ||
| PCT/IB2018/050063 WO2018127830A1 (en) | 2017-01-04 | 2018-01-04 | S-arrestin peptides and therapeutic uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3565823T3 true PL3565823T3 (pl) | 2024-10-28 |
Family
ID=61168133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18703620.7T PL3565823T3 (pl) | 2017-01-04 | 2018-01-04 | Peptydy S-arestyn oraz ich zastosowanie terapeutyczne |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11542316B2 (pl) |
| EP (1) | EP3565823B1 (pl) |
| JP (1) | JP7174492B2 (pl) |
| AU (1) | AU2018206358B2 (pl) |
| CA (1) | CA3049182A1 (pl) |
| ES (1) | ES2981555T3 (pl) |
| HU (1) | HUE067829T2 (pl) |
| PL (1) | PL3565823T3 (pl) |
| WO (1) | WO2018127830A1 (pl) |
| ZA (1) | ZA201904386B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3141084A1 (en) * | 2019-06-12 | 2020-12-17 | Vikram JUNEJA | Neoantigen compositions and uses thereof |
| GB201909774D0 (en) | 2019-07-08 | 2019-08-21 | Apitope Tech Bristol Limited | Method |
| GB201919222D0 (en) * | 2019-12-23 | 2020-02-05 | Apitope Int Nv | Composition |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4413938A1 (de) | 1994-04-21 | 1995-11-02 | Gerhild Dr Wildner | Peptide als Therapeutikum für Autoimmunerkrankungen |
| GB2373500B (en) * | 2000-02-04 | 2004-12-15 | Aeomica Inc | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| SI1311542T1 (sl) * | 2000-08-21 | 2009-02-28 | Apitope Technology Bristol Ltd | Tolerogenski peptidi |
| CA2656463C (en) * | 2006-06-28 | 2015-12-01 | Yeda Research And Development Co. Ltd. | Method of treatment of age-related macular degeneration |
| US9260506B2 (en) * | 2011-04-07 | 2016-02-16 | Oregon Health & Science University | Treatment of retinal disorders with recombinant T cell receptor ligand (RTL) |
| CN103501812A (zh) * | 2011-04-29 | 2014-01-08 | 西莱克塔生物科技公司 | 用于过敏症治疗的致耐受性合成纳米载体 |
| US20130058970A1 (en) * | 2011-09-06 | 2013-03-07 | Selecta Biosciences, Inc. | Induced tolerogenic dendritic cells to reduce systemic inflammatory cytokines |
| PL2917232T3 (pl) | 2012-11-12 | 2017-09-29 | Apitope International Nv | Pochodzące od czynnika VIII peptydy do zastosowania w leczeniu hemofilii A |
| BR112015010756B1 (pt) | 2012-11-16 | 2022-04-12 | United Biomedical, Inc | Composições de vacina para a doença do pé-e-boca (fmd),e uso das mesmas |
| US20140322188A1 (en) * | 2013-04-26 | 2014-10-30 | Enzo Biochem, Inc. | Tolerizing treatments for autoimmune disease |
| WO2015023504A1 (en) | 2013-08-12 | 2015-02-19 | Medlmmune, Llc | Methods for reducing exacerbation rates of asthma using benralizumab |
-
2018
- 2018-01-04 PL PL18703620.7T patent/PL3565823T3/pl unknown
- 2018-01-04 WO PCT/IB2018/050063 patent/WO2018127830A1/en not_active Ceased
- 2018-01-04 AU AU2018206358A patent/AU2018206358B2/en active Active
- 2018-01-04 CA CA3049182A patent/CA3049182A1/en active Pending
- 2018-01-04 ES ES18703620T patent/ES2981555T3/es active Active
- 2018-01-04 US US16/474,590 patent/US11542316B2/en active Active
- 2018-01-04 EP EP18703620.7A patent/EP3565823B1/en active Active
- 2018-01-04 HU HUE18703620A patent/HUE067829T2/hu unknown
- 2018-01-04 JP JP2019536212A patent/JP7174492B2/ja active Active
-
2019
- 2019-07-03 ZA ZA2019/04386A patent/ZA201904386B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7174492B2 (ja) | 2022-11-17 |
| AU2018206358A1 (en) | 2019-07-18 |
| ES2981555T3 (es) | 2024-10-09 |
| WO2018127830A1 (en) | 2018-07-12 |
| CA3049182A1 (en) | 2018-07-12 |
| EP3565823C0 (en) | 2024-05-29 |
| HUE067829T2 (hu) | 2024-11-28 |
| US11542316B2 (en) | 2023-01-03 |
| EP3565823A1 (en) | 2019-11-13 |
| JP2020503355A (ja) | 2020-01-30 |
| EP3565823B1 (en) | 2024-05-29 |
| ZA201904386B (en) | 2023-01-25 |
| US20190330298A1 (en) | 2019-10-31 |
| AU2018206358B2 (en) | 2021-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3720502A4 (en) | CYTOBIOLOGICAL PRODUCTS AND THEIR THERAPEUTIC USES | |
| IL267925B (en) | hsd17b13 variants and their uses | |
| PL3615565T3 (pl) | Tcr i peptydy | |
| IL265463A (en) | Therapeutic peptides related to mots-c | |
| SMT202300299T1 (it) | Nuovi polipeptidi e relativi usi medici | |
| IL256515A (en) | Therapeutic peptides and methods of use thereof | |
| SG11201708624YA (en) | Therapeutic antibodies and uses thereof | |
| ZA201905372B (en) | Therapeutic and neuroprotective peptides | |
| SG11202006669RA (en) | Peptides and uses thereof | |
| SG11201705759SA (en) | Cytotoxic hexim1 peptides and uses thereof | |
| EP3706771A4 (en) | BCL9 PEPTIDES AND VARIANTS THEREOF | |
| EP3313427A4 (en) | Therapeutic peptides and methods of use thereof | |
| IL272050B1 (en) | Synthetic proteins and their therapeutic uses | |
| IL265236A (en) | Multipurpose medical buildings and their uses | |
| ZA201904386B (en) | S-arrestin peptides and therapeutic uses thereof | |
| ZA201901942B (en) | Nnif and nnif-related peptides and related methods | |
| EP3399990A4 (en) | THERAPEUTIC COMPOSITIONS WITH PEPTIDES AND USES THEREOF | |
| IL270460B1 (en) | New compounds and their medicinal uses | |
| HUE062120T2 (hu) | Peptid-származék és alkalmazása | |
| HUP1700012A2 (en) | Novel proteins and use thereof | |
| EP3325499A4 (en) | Novel peptide and use thereof | |
| SG11201610918RA (en) | Peptides and uses thereof | |
| PT3664800T (pt) | Formulações terapêuticas que compreendem inibidor da cox-2 e utilizações das mesmas | |
| GB201705684D0 (en) | Novel compounds and therapeutic uses thereof | |
| HK40016468A (en) | S-arrestin peptides and therapeutic uses thereof |